Correlation Between Enliven Therapeutics and Hookipa Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Hookipa Pharma, you can compare the effects of market volatilities on Enliven Therapeutics and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Hookipa Pharma.

Diversification Opportunities for Enliven Therapeutics and Hookipa Pharma

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between Enliven and Hookipa is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Hookipa Pharma go up and down completely randomly.

Pair Corralation between Enliven Therapeutics and Hookipa Pharma

Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 0.61 times more return on investment than Hookipa Pharma. However, Enliven Therapeutics is 1.64 times less risky than Hookipa Pharma. It trades about -0.19 of its potential returns per unit of risk. Hookipa Pharma is currently generating about -0.36 per unit of risk. If you would invest  2,765  in Enliven Therapeutics on September 3, 2024 and sell it today you would lose (327.00) from holding Enliven Therapeutics or give up 11.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Enliven Therapeutics  vs.  Hookipa Pharma

 Performance 
       Timeline  
Enliven Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Enliven Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady basic indicators, Enliven Therapeutics may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Hookipa Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hookipa Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Enliven Therapeutics and Hookipa Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Enliven Therapeutics and Hookipa Pharma

The main advantage of trading using opposite Enliven Therapeutics and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.
The idea behind Enliven Therapeutics and Hookipa Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format